Edwards Lifesciences Corporation (BVMF:E1WL34)

Brazil flag Brazil · Delayed Price · Currency is BRL
113.41
+1.55 (1.39%)
At close: Dec 4, 2025
6.84%
Market Cap 270.72B
Revenue (ttm) 31.36B
Net Income (ttm) 7.29B
Shares Out n/a
EPS (ttm) 12.42
PE Ratio 37.13
Forward PE 31.15
Dividend n/a
Ex-Dividend Date n/a
Volume 2
Average Volume 155
Open 113.41
Previous Close 111.86
Day's Range 113.41 - 113.41
52-Week Range 98.15 - 117.36
Beta 0.97
RSI 54.57
Earnings Date Feb 13, 2026

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solution... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1958
Employees 15,800
Stock Exchange Brazil Stock Exchange
Ticker Symbol E1WL34
Full Company Profile

Financial Performance

In 2024, Edwards Lifesciences's revenue was $5.44 billion, an increase of 8.57% compared to the previous year's $5.01 billion. Earnings were $4.17 billion, an increase of 197.68%.

Financial numbers in USD Financial Statements

News

There is no news available yet.